Atlas Trials

Newly Diagnosed Glioblastoma

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Newly Diagnosed Glioblastoma

RecordFirmDate
The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab (NCT05235737)Medical University of Silesia2022-03-01
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (NCT05163080)MimiVax, LLC2021-11-18
Phase 2 Study of CAN008 in Subjects With GBM (NCT05447195)CANbridge Life Sciences Ltd.2021-10-10
Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma (NCT04840069)St. Joseph's Hospital and Medical Center, Phoenix2021-06-07
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma (NCT04474353)Stanford University2021-05-21
A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT) (NCT04600817)TJ Biopharma Co., Ltd.2020-12-31
Pembrolizumab for Newly Diagnosed Glioblastoma (NCT03899857)University of Zurich2020-10-21
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma (NCT04477200)University of Michigan Rogel Cancer Center2020-08-05
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors (NCT04478279)Sapience Therapeutics2020-07-01
Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma (NCT04065087)Genexine, Inc.2019-08-22
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma (NCT03782415)MediciNova2018-12-29
A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma (NCT03345095)European Organisation for Research and Treatment of Cancer - EORTC2018-07-26
Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma (NCT03400917)Aivita Biomedical, Inc.2018-06-20
Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma (NCT03619239)Genexine, Inc.2018-06-20
Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma (NCT01805453)Assistance Publique - Hôpitaux de Paris2013-03-29

Track Newly Diagnosed Glioblastoma automatically

Every clearance here is in the API, with alerts when new ones post.